ALLOCAR T
Dead / Cancelled — Cancelled — Section 18 (TTAB) (as of 17 Nov 2025)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97889420
- Registration number
- 7307152
- Mark type
- Stylized text
- Filed
- 14 Apr 2023
- Registered
- 13 Feb 2024
- Attorney of record
- THOMAS L. HOLT
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy
Owner
- Allogene Therapeutics, Inc., South San Francisco, CA, US
- Allogene Therapeutics, Inc., South San Francisco, CA, US
Prosecution history
- 17 Nov 2025 — CANCELLED SECTION 18-TOTAL
- 17 Nov 2025 — CANCELLATION TERMINATED NO. 999999
- 29 Sept 2025 — CANCELLATION GRANTED NO. 999999
- 30 Aug 2024 — CANCELLATION INSTITUTED NO. 999999
- 13 Feb 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 Feb 2024 — REGISTERED-SUPPLEMENTAL REGISTER
- 10 Jan 2024 — APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
- 10 Jan 2024 — LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
- 10 Jan 2024 — ASSIGNED TO EXAMINER
- 31 Dec 2023 — PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
- 31 Dec 2023 — ASSIGNED TO LIE
- 02 Aug 2023 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 28 Jun 2023 — LETTER OF PROTEST EVIDENCE FORWARDED
- 09 May 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 18 Apr 2023 — NEW APPLICATION ENTERED